|
| |
Image Results
Loading...
Loading...
ANASTROZOLE Pages on BioPortfolio:
Results from other life science and pharmaceutical sites:
Anastrozole - Wikipedia, the free encyclopedia
Anastrozole (INN, trade name Arimidex, AstraZeneca) is a drug used to treat breast cancer after surgery and for metastases in post-menopausal women. ...
http://en.wikipedia.org/wiki/Anastrozole...
|
Anastrozole: MedlinePlus Drug Information
Features information about dosage, usage, warnings, and side effects.
http://www.nlm.nih.gov/medlineplus/druginfo/meds/a696018.htm...
|
Anastrozole alone or in combination with tamoxifen versus ...
We aimed to compare the safety and efficacy outcomes of tamoxifen with those of anastrozole alone and the combination of anastrozole plus tamoxifen for 5 ...
http://www.ncbi.nlm.nih.gov/pubmed/12090977...
|
Arimidex (anastrozole) - oral aromatase inhibitor - AstraZeneca
Arimidex (anostrozole) information, an oral aromatase inhibitor by AstraZeneca.
http://www.astrazeneca.com/medicines/oncology/?itemId=388805...
|
Anastrozole -- AHFS Consumer Medication Information -- NCBI Bookshelf
1 Jun 2009 ... Anastrozole is used alone or with other treatments, such as surgery or radiation , to treat early breast cancer in women who have experienced ...
http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=meds&part...
|
Anastrozole--R&S PharmChem Co.,Ltd.
Anastrozole is used to treat advanced breast cancer in postmenopausal women who have failed to respond to therapy with other drugs, such as tamoxifen ...
http://www.rspharmchem.com/anstrozole.htm...
|
Anastrozole is superior to tamoxifen as first-line therapy for ...
PURPOSE: The efficacy and tolerability of anastrozole (Arimidex; AstraZeneca, Wilmington, DE, and Macclesfield, United Kingdom) and tamoxifen were compared ...
http://www.ncbi.nlm.nih.gov/pubmed/11078488...
|
Anastrozole Replaces Adjuvant Tamoxifen
3 Dec 2003 ... Switch to aromatase inhibitor cuts risk of relapse and death in breast cancer trial.
http://www.medscape.com/viewarticle/465452...
|
Anastrozole alone or in combination with tamoxifen versus ...
The benefit generated by anastrozole in terms of DFS was even greater in patients with hormone receptor-positive tumors (HR, 0.82; 95% CI, 0.70-0.96; ...
http://www.ncbi.nlm.nih.gov/pubmed/14584060...
|
British Journal of Cancer - Abstract of article: Pharmacokinetics ...
Pharmacokinetics of anastrozole and tamoxifen alone, and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women: ...
http://www.nature.com/bjc/journal/v85/n3/abs/6691925a.html...
|
|